2seventy bio, Inc. (TSVT) Financials

TSVT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 565.4 million 310.1 million
2023-09-30 640.8 million 334.4 million
2023-06-30 705.7 million 338.2 million
2023-03-31 742.4 million 341.1 million

TSVT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -64.7 million 5.0 million
2023-09-30 -24.3 million 9.8 million
2023-06-30 -36.6 million 7.7 million
2023-03-31 -55.2 million 9.7 million

TSVT Net Income

No data available :(

TSVT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 217.0 million - 256.7 million
2023-09-30 250.6 million - 260.2 million
2023-06-30 282.8 million - 263.6 million
2023-03-31 339.9 million - 267.0 million

TSVT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 51.4 million
2023-09-30 51.2 million
2023-06-30 51.0 million
2023-03-31 43.5 million

TSVT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.1 million 48.2 million 16.2 million -
2023-09-30 2.7 million 51.3 million 13.0 million -
2023-06-30 4.0 million 60.0 million 19.5 million -
2023-03-31 6.1 million 68.2 million 20.8 million -

TSVT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 10.7 million 6.2 million
2023-09-30 12.0 million 5.0 million
2023-06-30 36.0 million 4.5 million
2023-03-31 41.6 million 4.3 million

TSVT

Price: $4.59

52 week price:
1.54
12.69

Earnings Per Share: -4.42 USD

P/E Ratio: -1.59

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 673900

Market Capitalization: 252.5 million

Links: